BioFuels Journal

Emeryville, CA - Dec. 29, 2016 - Amyris, Inc. (Nasdaq:AMRS), the industrial bioscience company, today announced it has signed a definitive agreement with affiliates of Fidelity Management and Research Company (‘Fidelity') to exchange $15.3 million of 3% notes due March 2017 into Amyris's existing 9.5% notes due April 2019.

In addition, with the effect of this exchange, as disclosed on October 12, 2016, senior secured debt held by Stegodon Corporation totaling $28.6 million, currently due February 2017, will be extended to October 2018.

More details of this transaction are available in the Form 8-K filed on December 29.

The exchange is subject to customary closing conditions, including obtaining certain required approvals.

"We promised earlier in the year that we would work hard to restructure near term debt maturities in Q4 while improving our balance sheet, and this transaction is another example of our execution," said John Melo, Amyris President and CEO.

"We're very pleased with the continued support of Fidelity and the terrific momentum we are experiencing in our underlying business as we are in process of achieving another record quarter."

For more information, please contact Peter DeNardo at 510-740-7481.

See Related Websites/Articles:

• Amyris

more ADVANCED BIOFUELS...